-
1
-
-
0023743171
-
Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
-
J.W. Funder, P.T. Pearce, R. Smith, and A.I. Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science 242 1988 583 585
-
(1988)
Science
, vol.242
, pp. 583-585
-
-
Funder, J.W.1
Pearce, P.T.2
Smith, R.3
Smith, A.I.4
-
2
-
-
78049291946
-
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
-
P. Ferrari The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension Biochim Biophys Acta 1802 2010 1178 1187
-
(2010)
Biochim Biophys Acta
, vol.1802
, pp. 1178-1187
-
-
Ferrari, P.1
-
3
-
-
0038306946
-
Hypertension and the cortisol-cortisone shuttle
-
M. Quinkler, and P.M. Stewart Hypertension and the cortisol-cortisone shuttle J Clin Endocrinol Metab 88 2003 2384 2392
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2384-2392
-
-
Quinkler, M.1
Stewart, P.M.2
-
5
-
-
0035542955
-
In vivo 11β-HSD-2 activity: Variability, salt-sensitivity, and effect of licorice
-
P. Ferrari, A. Sansonnens, B. Dick, and F.J. Frey In vivo 11β-HSD-2 activity: variability, salt-sensitivity, and effect of licorice Hypertension 38 2001 1330 1336
-
(2001)
Hypertension
, vol.38
, pp. 1330-1336
-
-
Ferrari, P.1
Sansonnens, A.2
Dick, B.3
Frey, F.J.4
-
6
-
-
0030002945
-
Apparent mineralocorticoid excess: Type i and type II
-
F. Mantero, M. Palermo, M.D. Petrelli, R. Tedde, P.M. Stewart, and C.H. Shackleton Apparent mineralocorticoid excess: type I and type II Steroids 61 1996 193 196
-
(1996)
Steroids
, vol.61
, pp. 193-196
-
-
Mantero, F.1
Palermo, M.2
Petrelli, M.D.3
Tedde, R.4
Stewart, P.M.5
Shackleton, C.H.6
-
7
-
-
0025136771
-
Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess
-
S. Ulick, R. Tedde, and F. Mantero Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess J Clin Endocrinol Metab 70 1990 200 206
-
(1990)
J Clin Endocrinol Metab
, vol.70
, pp. 200-206
-
-
Ulick, S.1
Tedde, R.2
Mantero, F.3
-
8
-
-
0033988654
-
The use of deuterium-labeled cortisol for in vivo evaluation of renal 11β-HSD activity in man: Urinary excretion of cortisol, cortisone and their A-ring reduced metabolites
-
Y. Kasuya, H. Shibasaki, and T. Furuta The use of deuterium-labeled cortisol for in vivo evaluation of renal 11β-HSD activity in man: urinary excretion of cortisol, cortisone and their A-ring reduced metabolites Steroids 65 2000 89 97
-
(2000)
Steroids
, vol.65
, pp. 89-97
-
-
Kasuya, Y.1
Shibasaki, H.2
Furuta, T.3
-
9
-
-
0030832511
-
Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo
-
R. Best, and B.R. Walker Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo Clin Endocrinol (Oxf) 47 1997 231 236
-
(1997)
Clin Endocrinol (Oxf)
, vol.47
, pp. 231-236
-
-
Best, R.1
Walker, B.R.2
-
10
-
-
0029847585
-
Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man
-
M. Palermo, C.H. Shackleton, F. Mantero, and P.M. Stewart Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man Clin Endocrinol (Oxf) 45 1996 605 611
-
(1996)
Clin Endocrinol (Oxf)
, vol.45
, pp. 605-611
-
-
Palermo, M.1
Shackleton, C.H.2
Mantero, F.3
Stewart, P.M.4
-
11
-
-
33750075481
-
Urinary free cortisol and cortisone excretion in healthy individuals: Influence of water loading
-
M. Fenske Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading Steroids 71 2006 1014 1018
-
(2006)
Steroids
, vol.71
, pp. 1014-1018
-
-
Fenske, M.1
-
13
-
-
60449111471
-
Simultaneous determination of androstenedione, 11β- hydroxyandrostenedione, and testosterone in human plasma by stable isotope dilution mass spectrometry
-
A. Yokokawa, K. Yamamoto, Y. Omori, H. Shibasaki, Y. Shinohara, Y. Kasuya, and T. Furuta Simultaneous determination of androstenedione, 11β-hydroxyandrostenedione, and testosterone in human plasma by stable isotope dilution mass spectrometry J Chromatogr B 877 2009 621 626
-
(2009)
J Chromatogr B
, vol.877
, pp. 621-626
-
-
Yokokawa, A.1
Yamamoto, K.2
Omori, Y.3
Shibasaki, H.4
Shinohara, Y.5
Kasuya, Y.6
Furuta, T.7
-
14
-
-
0026731695
-
Stable isotope dilution mass spectrometry for the simultaneous determination of cortisol, cortisone, prednisolone and prednisone in plasma
-
H. Shibasaki, T. Furuta, and Y. Kasuya Stable isotope dilution mass spectrometry for the simultaneous determination of cortisol, cortisone, prednisolone and prednisone in plasma J Chromatogr 579 1992 193 202
-
(1992)
J Chromatogr
, vol.579
, pp. 193-202
-
-
Shibasaki, H.1
Furuta, T.2
Kasuya, Y.3
-
15
-
-
67349238613
-
Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity
-
K. Müssig, T. Remer, A. Fritsche, H.U. Häring, and C. Maser-Gluth Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity Steroids 74 2009 742 745
-
(2009)
Steroids
, vol.74
, pp. 742-745
-
-
Müssig, K.1
Remer, T.2
Fritsche, A.3
Häring, H.U.4
Maser-Gluth, C.5
-
16
-
-
55549117108
-
Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children
-
L. Shi, C. Maser-Gluth, and T. Remer Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children Steroids 73 2008 1446 1451
-
(2008)
Steroids
, vol.73
, pp. 1446-1451
-
-
Shi, L.1
Maser-Gluth, C.2
Remer, T.3
-
17
-
-
33748460999
-
Physiologic roles of 11β-hydroxysteroid dehydrogenase type 2 in kidney
-
Y. Isomura, T. Mune, H. Morita, T. Suwa, N. Takada, Y. Yamamoto, and J. Takeda Physiologic roles of 11β-hydroxysteroid dehydrogenase type 2 in kidney Metabolism 55 2006 1352 1357
-
(2006)
Metabolism
, vol.55
, pp. 1352-1357
-
-
Isomura, Y.1
Mune, T.2
Morita, H.3
Suwa, T.4
Takada, N.5
Yamamoto, Y.6
Takeda, J.7
|